
BioNTech SE BNTX
$ 110.23
1.31%
Annual report 2024
added 02-28-2026
BioNTech SE ROCE Ratio 2011-2026 | BNTX
Annual ROCE Ratio BioNTech SE
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | -4.81 | -27.52 | -10.22 | -28.35 | - | - | - | - | - | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -4.81 | -28.35 | -17.73 |
ROCE Ratio of other stocks in the Biotechnology industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
2.89 | - | 2.43 % | $ 254 M | ||
|
Acer Therapeutics
ACER
|
146.85 | - | 2.71 % | $ 14 M | ||
|
AbbVie
ABBV
|
-461.01 | $ 232.08 | 3.29 % | $ 411 B | ||
|
AbCellera Biologics
ABCL
|
-16.8 | $ 3.61 | 0.56 % | $ 1.08 B | ||
|
Abeona Therapeutics
ABEO
|
-317.92 | $ 5.12 | -1.54 % | $ 109 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
-73.67 | $ 4.66 | -0.85 % | $ 773 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
31.5 | $ 24.56 | -0.32 % | $ 4.07 B | ||
|
Achieve Life Sciences
ACHV
|
-90.77 | $ 4.56 | -3.59 % | $ 90.4 M | ||
|
AC Immune SA
ACIU
|
-27.26 | $ 2.93 | -1.01 % | $ 229 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
17.36 | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
-180.78 | - | -10.17 % | $ 12.2 K | ||
|
Aclaris Therapeutics
ACRS
|
-74.09 | $ 2.87 | -8.31 % | $ 352 M | ||
|
Biophytis SA
BPTS
|
-325.06 | - | -13.47 % | $ 169 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-29.3 | - | - | $ 1.01 B | ||
|
Adagene
ADAG
|
-46.22 | $ 2.96 | -4.67 % | $ 167 M | ||
|
ADC Therapeutics SA
ADCT
|
-48.11 | $ 4.1 | -0.73 % | $ 105 M | ||
|
Adial Pharmaceuticals
ADIL
|
-203.65 | $ 2.53 | - | $ 16.4 M | ||
|
ADMA Biologics
ADMA
|
40.11 | $ 15.57 | 2.57 % | $ 3.71 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-60.13 | - | - | $ 26.5 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
-26.11 | $ 16.02 | -2.67 % | $ 2.43 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-61.36 | - | -1.52 % | $ 24.7 M | ||
|
ADiTx Therapeutics
ADTX
|
-5611.16 | $ 0.46 | -4.63 % | $ 6.06 K | ||
|
Midatech Pharma plc
MTP
|
-337.43 | - | -18.52 % | $ 27.3 M | ||
|
Agenus
AGEN
|
99.51 | $ 3.33 | -0.89 % | $ 1.19 M | ||
|
Agios Pharmaceuticals
AGIO
|
-39.57 | $ 30.23 | 0.83 % | $ 1.75 B | ||
|
AIM ImmunoTech
AIM
|
-51.79 | $ 0.91 | -8.59 % | $ 43.8 M | ||
|
Akebia Therapeutics
AKBA
|
72.06 | $ 1.31 | -0.76 % | $ 337 M | ||
|
Akari Therapeutics, Plc
AKTX
|
-97.36 | $ 0.24 | -8.87 % | $ 5.73 B | ||
|
ARCA biopharma
ABIO
|
-23.06 | - | 1052.0 % | $ 415 M | ||
|
Acorda Therapeutics
ACOR
|
167.74 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
-25.04 | - | 4.01 % | $ 150 M | ||
|
Aldeyra Therapeutics
ALDX
|
-79.69 | $ 5.46 | -0.73 % | $ 328 M | ||
|
Alector
ALEC
|
-509.01 | $ 2.43 | -5.08 % | $ 250 M | ||
|
Aligos Therapeutics
ALGS
|
-95.71 | $ 7.03 | -6.27 % | $ 452 M | ||
|
Adverum Biotechnologies
ADVM
|
-196.79 | - | - | $ 86.2 M | ||
|
Alkermes plc
ALKS
|
13.96 | $ 30.1 | -2.05 % | $ 4.96 B | ||
|
Институт стволовых клеток человека
ISKJ
|
15.18 | - | - | - | ||
|
Allogene Therapeutics
ALLO
|
-63.98 | $ 2.78 | 1.83 % | $ 436 M | ||
|
AIkido Pharma
AIKI
|
-28.92 | - | 1.93 % | $ 17.4 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
63.56 | $ 332.92 | 0.51 % | $ 43.6 B | ||
|
Akero Therapeutics
AKRO
|
-38.05 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
-37.16 | - | 0.23 % | $ 488 M | ||
|
Altimmune
ALT
|
-80.08 | $ 4.31 | -3.36 % | $ 306 M | ||
|
Albireo Pharma
ALBO
|
-70.32 | - | -0.23 % | $ 916 M | ||
|
ALX Oncology Holdings
ALXO
|
-125.39 | $ 2.11 | -10.21 % | $ 110 M | ||
|
Allena Pharmaceuticals
ALNA
|
-252.54 | - | 3.16 % | $ 1.9 M | ||
|
Amgen
AMGN
|
104.87 | $ 388.16 | 2.33 % | $ 209 B | ||
|
Aileron Therapeutics
ALRN
|
-119.71 | - | 10.36 % | $ 9.8 M | ||
|
AlloVir
ALVR
|
-57.76 | - | 4.14 % | $ 49.1 M |